san 202791 has been researched along with cyclic gmp in 1 studies
| Studies (san 202791) | Trials (san 202791) | Recent Studies (post-2010) (san 202791) | Studies (cyclic gmp) | Trials (cyclic gmp) | Recent Studies (post-2010) (cyclic gmp) |
|---|---|---|---|---|---|
| 31 | 0 | 2 | 22,346 | 333 | 4,062 |
| Protein | Taxonomy | san 202791 (IC50) | cyclic gmp (IC50) |
|---|---|---|---|
| Phosphodiesterase | Bos taurus (cattle) | 0.1 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | 2.4 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 2.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baik, YH; French, JF; Rapoport, RM; Schwartz, A | 1 |
1 other study(ies) available for san 202791 and cyclic gmp
| Article | Year |
|---|---|
Dihydropyridine Ca2+ channel agonists and antagonists potentiate ultraviolet light-induced relaxation through cyclic GMP formation in porcine coronary artery.
Topics: Animals; Calcium Channel Agonists; Calcium Channel Blockers; Coronary Vessels; Cyclic GMP; Dihydropyridines; In Vitro Techniques; Muscle Relaxation; Muscle, Smooth, Vascular; Stereoisomerism; Swine; Ultraviolet Rays | 1994 |